Svp Biopharma Partnerships
CurrentRareCyte is an expert service provider in the development of multi-biomarker Circulating Tumor Cell (along with other rare cell) assays and highly multiplexed (up to 21 biomarker) tissue analysis in support of Biopharma research and exploratory endpoints. The RareCyte infrastructure of CLIA lab, ISO13485 and Quality Management System delivers high quality.